Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FY5JK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,307
Award facts
- Contract value 100% obligated
- $17,307.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,307.03 to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets (30-count units) on November 17, 2025, with completion scheduled for November 18, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award.
XELJANZ XR is a branded pharmaceutical used to treat rheumatoid arthritis and other inflammatory conditions, reflecting AmerisourceBergen's role as a critical supplier of specialty medications to the federal healthcare system. As a major pharmaceutical distributor, AmerisourceBergen serves the military and veteran healthcare systems through the DLA's comprehensive global pharmaceutical support vehicle, which enables delivery of a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order exemplifies the company's capability to fulfill federal medical procurement requirements through open competition, with the parent IDC serving as a flexible contracting mechanism for the Defense Health Agency and other government healthcare organizations.
Quick answers
Who was awarded contract SPE2DR26FY5JK?
SPE2DR26FY5JK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FY5JK worth?
The government has obligated $17,307 on SPE2DR26FY5JK.
Is contract SPE2DR26FY5JK an order under another contract?
Yes. SPE2DR26FY5JK is a delivery order under SPE2DR25D1006, an indefinite delivery contract.
Was contract SPE2DR26FY5JK competed?
The extent of competition for SPE2DR26FY5JK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award